Skip to main content

What the FDA labels say about taking them together

Pemetrexed and piroxicam

Piroxicam's FDA label of August 19, 2026 names pemetrexed in its drug interactions section; the pemetrexed labels PlainMeds reads (4) do not name piroxicam. The piroxicam label: “Concomitant use of piroxicam and pemetrexed may increase the risk of pemetrexed-associated myelosuppression, renal, and GI toxicity.”

Check it at the source: the pemetrexed FDA label on DailyMed (effective October 8, 2025, Avyxa Pharma, LLC); the piroxicam FDA label on DailyMed (effective August 19, 2026, Teva Pharmaceuticals USA, Inc.).

What does the pemetrexed label say about piroxicam?

Pemetrexed's label (effective October 8, 2025) and its 3 other brand-application labels do not name piroxicam in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (AXTLE), Avyxa Pharma, LLC, effective October 8, 2025 (SPL set 9582c46c-d8b0-44b7-a2ee-9c86f5e9b7b1), via openFDA; the full label on DailyMed

What does the piroxicam label say about pemetrexed?

Piroxicam label, drug interactions

Pemetrexed Clinical Impact: Concomitant use of piroxicam and pemetrexed may increase the risk of pemetrexed-associated myelosuppression, renal, and GI toxicity (…). Intervention: During concomitant use of piroxicam and pemetrexed, in patients with renal impairment whose creatinine clearance ranges from 45 to 79 mL/min, monitor for myelosuppression, renal and GI toxicity. …

Source: FDA drug label (Piroxicam), Teva Pharmaceuticals USA, Inc., effective August 19, 2026 (SPL set f1123fe1-b79c-430b-8548-08cd6e518482), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

15Pemetrexed generic labelers
10Piroxicam generic labelers
PemetrexedPiroxicam
Labeled forLung cancerOsteoarthritis, Rheumatoid arthritis
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$0.215 per capsule 20 mg capsule
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?